Earnings Call · Q1 FY2026·2026-05-12

Q1 26EPS -36.50%·Rev n/aQ4 25EPS +100.00%*·Rev n/aQ3 25EPS -100.00%*·Rev n/aQ2 25EPS -100.00%*·Rev n/a⚠ consensus missing

Lineage Cell Therapeutics, Inc. LCTX

Ioana C. Hone — Chief Financial Officer

Brian Culley — President and CEO

Jill Ann Howe — Chief Financial Officer

+1.5%1d on move date+1.7% vs SPY3d0.0%5d−5.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LCTX calls or request research access.

More LCTX calls Browse calls Request research access